Kim, J.J. and Hijazi, Z.M. (2002) Clinical Outcomes and Costs of Amplatzer Transcatheter Closure as Compared with Surgical Closure of Ostium Secundum Atrial Septal Defects. Medical Science Monitor, 8, CR787-91.
https://pubmed.ncbi.nlm.nih.gov/12503036/

has been cited by the following article:

• TITLE: To What Extent Can Transcatheter Devices Replace Open-Heart Surgery in the Treatment of Cardiac Septal Defects?

  AUTHORS: Aathi S. Somanathan

  KEYWORDS: Cardiac Septal Defect, Atrial, Transthoracic, Transcatheter, Septal Occluder, Hybrid

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.12 No.10, October 31, 2022

  ABSTRACT: Transcatheter treatments are widespread, having the advantages of being less invasive than surgery with quicker recovery times and reduced physical and psychological consequences. However correct patient selection is vital to optimise outcomes. In the case of an isolated atrial septal defect (ASD), transcatheter closure is preferred. Whilst multiple or large ASDs or ventricular septal defects (VSDs) are best treated through the transthoracic approach. Furthermore, the development of the transcatheter approach has yielded devices that can be used in the transthoracic approach resulting in hybrid techniques. This article aims to evaluate both transcatheter devices and open-heart surgery in the treatment of cardiac septal defects. A brief discussion follows on from the causes and history of cardiac defect treatments.